Versant Capital Management »

Castle Biosciences shares owned by Versant Capital Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1k 181 22.77
2025-06-30 $2.6k 126 20.42

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Microsoft Stock (MSFT)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Ishares S&p Global Energy Etf (IXC)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Vanguard Total Stk Mkt Etf (VTI)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Ishares Gold Trust Micro Etf Of Benef Interest Etf (IAUM)

View all positions for Versant Capital Management

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Nuveen
Braidwell
State Street Corporation
AIGH Capital Management
Geode Capital Management
Daniel D. Thurber
Allianz Asset Management
Palisade Capital Management
Millennium Management
Renaissance Technologies

View all funds holding Castle Biosciences